A study by Qiu et al. demonstrated that miR-150-5p notably reduced levels of the suppressor of cytokine signaling 1 (SOCS1) and promoted the growth of RA-FLSs, which suggested its potential role as a therapeutic target in RA [80]. Here, SOCS1 is linked to rheumatoid arthritis.